Costa Mesa, CA (August 16, 2022) – inVibe has had a busy year; for the fourth year in a row, joining the ranks of the Inc. 5000 list of fastest-growing private companies and merging with the decentralized clinical trial platform, THREAD. Earning the rank of #3,519 on the annual list, inVibe continues to revolutionize healthcare-focused market research.
“Digital innovation has helped companies deeply understand the needs of customers, and in no industry is that more important than healthcare,” insists Fabio Gratton, inVibe Co-founder, CEO, and Chief Experience Officer at THREAD. “We built inVibe with the goal of removing all the barriers between discovering the needs and expectations of patients and professionals and the life science companies that serve them. Ranking on the Inc. 5000 list validates our success, and merging with THREAD paves the way for even greater public health benefit.”
Through a mix of human expertise and technology, inVIbe has created a new paradigm for market research. By seamlessly integrating voice-based data collection from smartphones, linguistic and machine learning analytics, and dynamic reporting techniques, inVibe provides invaluable end user insights across the entire drug development and distribution life cycle. And by providing these capabilities to clinicians managing decentralized clinical trials, the industry is further empowered to create cutting-edge therapeutics for increasingly diverse populations.
At the heart of the inVibe market research revolution is their ability to tap into the depth and emotional resonance of the human voice. Conventional market research surveys and even observational studies collect a limited amount of data, which is often biased. inVibe instead collects megabytes of voice data and then fed into the industry’s most advanced analytical platform. The multidimensional voice input is the source of unique insights that drive actionable recommendations for optimizing clinical trials and downstream communications.
“Apple, Google, and Amazon are valued at over a trillion dollars thanks to their unprecedented ability to understand the consumer experience,” adds Fabio. “inVibe has adapted many of these same tools for healthcare market research. If Alexa can drive billions in eCommerce, then there’s no reason inVibe can’t offer similar innovation and power to better understand consumers for pharma. We’re honored to be ranked for the fourth year on the Inc. 5000, and feel our merger with THREAD adds a new dimension to our proven impact on public health.”
For more information about inVibe and how you can listen to your customers in a new way, please visit https://www.invibe.co. And for more information about their new parent company, THREAD, visit https://www.threadresearch.com.
About InVibe
inVibe has revolutionized market research for healthcare companies through voice data collection, machine learning, linguistic analytics, and dynamic reporting. Their unique approach has empowered major pharmaceutical companies, marketing agencies, universities, and healthcare startups with the capabilities to better understand patients, caregivers, and healthcare professionals—and translate those insights into actionable recommendations for brand growth. For more information, please visit https://www.invibe.co.
About THREAD
THREAD® is the industry-leading decentralized clinical trials technology and consulting service provider, helping biopharma and CROs decentralize clinical research and enable electronic clinical outcome assessments (eCOA) for sites, participants, caregivers and home health professionals. Through its unified platform, THREAD is making studies 30% more efficient and five times more inclusive and diverse. Backed by health care investors Water Street Healthcare Partners and JLL Partners, THREAD is recognized as a leader by Everest Group’s Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021, Frost & Sullivan’s 2021 Customer Value Leadership Award, as well as a long list of accolades. Visit THREADresearch.com to learn more.
About Inc. Media
Its prestigious Inc. 5000 list, produced yearly since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 allows the founders of the best business an opportunity to engage with an exclusive community of their peers and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Vision Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. Take a look at the 2022 data.
Methodology
Companies on the 2022 Inc. 5000 are ranked according to percentage revenue growth from 2017 to 2021. To qualify, companies must have been founded and generating revenue by March 31, 2017. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2021. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2017 is $100,000; the minimum for 2021 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Growth rates used to determine company rankings were calculated to three decimal places. There was one tie on this year’s Inc. 5000. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.
